Efficacy, Onset of Action and Tolerability of Moxifloxacin in Patients with Community-Acquired Pneumonia: Results of a Postmarketing Surveillance Study

Author: Landen H.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.21, Iss.12, 2001-12, pp. : 801-811

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content